APA

Vairaktaris E., Yapijakis C., Serefoglou Z., Vylliotis A., Ries J., Nkenke E., Wiltfang J., Derka S., Vassiliou S., Springer I., Kessler P. & Neukam F. W. (20070807). Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. : Oral oncology.

Chicago

Vairaktaris E, Yapijakis C, Serefoglou Z, Vylliotis A, Ries J, Nkenke E, Wiltfang J, Derka S, Vassiliou S, Springer I, Kessler P and Neukam F W. 20070807. Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. : Oral oncology.

Harvard

Vairaktaris E., Yapijakis C., Serefoglou Z., Vylliotis A., Ries J., Nkenke E., Wiltfang J., Derka S., Vassiliou S., Springer I., Kessler P. and Neukam F. W. (20070807). Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. : Oral oncology.

MLA

Vairaktaris E, Yapijakis C, Serefoglou Z, Vylliotis A, Ries J, Nkenke E, Wiltfang J, Derka S, Vassiliou S, Springer I, Kessler P and Neukam F W. Plasminogen activator inhibitor-1 polymorphism is associated with increased risk for oral cancer. : Oral oncology. 20070807.